Citi reiterated a Buy rating and $1,190 price target on Eli Lilly (LLY), saying the firm expects a positive read-through to the shares on FDA’s ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Novo Nordisk is a great pick to buy with the stock near its 52-week low. Vertex Pharmaceuticals is helping patients and ...

Hashtag, a weekly place for broader context. Saturday Hashtag: #DataDistortion originally appeared on WhoWhatWhy ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of ...

"Billionaire" and "successful hedge fund manager" are titles that carry significant weight on Wall Street. These and others ...

The bioengineered protein drugs market is experiencing a paradigm shift, with pharmaceutical and biotech companies leveraging advanced biopharmaceuti ...

Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...

Senators ask if contracts between drugmakers and telehealth companies violate the federal anti-kickback statute.

Roche and Zealand Pharma inked a $5.3 billion deal Wednesday to collaborate on a weight-loss drug in the amylin class.